{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:05:12Z","timestamp":1791237912426,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371815"],"award-info":[{"award-number":["82371815"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72630-6","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T09:40:24Z","timestamp":1740735624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Exosomes carrying adipose mesenchymal stem cells function alleviate scleroderma skin fibrosis by inhibiting the TGF-\u03b21\/Smad3 axis"],"prefix":"10.1038","volume":"15","author":[{"given":"Yu","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"10373","key":"72630_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","volume":"401","author":"ER Volkmann","year":"2023","unstructured":"Volkmann, E. R., Andr\u00e9asson, K. & Smith, V. Systemic sclerosis. Lancet (London England)401(10373), 304\u2013318 (2023).","journal-title":"Lancet (London England)"},{"issue":"11","key":"72630_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41584-023-01032-1","volume":"19","author":"A Leask","year":"2023","unstructured":"Leask, A., Naik, A. & Stratton, R. J. Back to the future: Targeting the extracellular matrix to treat systemic sclerosis. Nat. Rev. Rheumatol.19(11), 713\u2013723 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"12","key":"72630_CR3","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1136\/ard-2022-222564","volume":"81","author":"Y Allanore","year":"2022","unstructured":"Allanore, Y. et al. Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: Data from SENSCIS-ON. Ann. Rheum. Dis.81(12), 1722\u20131729 (2022).","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"72630_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/art.41965","volume":"74","author":"M Kuwana","year":"2022","unstructured":"Kuwana, M. et al. Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: Subgroup analyses by autoantibody status and modified rodnan skin thickness score. Arthritis Rheumatol. (Hoboken, NJ)74(3), 518\u2013526 (2022).","journal-title":"Arthritis Rheumatol. (Hoboken, NJ)"},{"key":"72630_CR5","doi-asserted-by":"crossref","unstructured":"Allanore, Y., Simms, R., Distler, O. et al. Systemic sclerosis. Nat. Rev. Dis. Primers1(15002) (2015).","DOI":"10.1038\/nrdp.2015.2"},{"issue":"1","key":"72630_CR6","first-page":"Cd010908","volume":"1","author":"H Barnes","year":"2018","unstructured":"Barnes, H. et al. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. Cochrane Database Syst. Rev.1(1), Cd010908 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"72630_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","volume":"8","author":"D Khanna","year":"2020","unstructured":"Khanna, D. et al. Tocilizumab in systemic sclerosis: A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir. Med.8(10), 963\u2013974 (2020).","journal-title":"Lancet Respir. Med."},{"issue":"12","key":"72630_CR8","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/rheumatology\/kev117","volume":"54","author":"JM van Laar","year":"2015","unstructured":"van Laar, J. M., Naraghi, K. & Tyndall, A. Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis. Rheumatol. (Oxford, England)54(12), 2126\u20132133 (2015).","journal-title":"Rheumatol. (Oxford, England)"},{"key":"72630_CR9","doi-asserted-by":"crossref","unstructured":"Cras, A., Farge, D., Carmoi, T. et al. Update on mesenchymal stem cell-based therapy in lupus and scleroderma. Arthritis Res. Ther.17(301) (2015).","DOI":"10.1186\/s13075-015-0819-7"},{"key":"72630_CR10","doi-asserted-by":"crossref","unstructured":"Peltzer, J., Aletti, M., Frescaline, N. et al. Mesenchymal stromal cells based therapy in systemic sclerosis: Rational and challenges. Front. Immunol. 9(2013) (2018).","DOI":"10.3389\/fimmu.2018.02013"},{"key":"72630_CR11","doi-asserted-by":"crossref","unstructured":"Rozier, P., Maria, A., Goulabchand, R. et al. Mesenchymal stem cells in systemic sclerosis: allogenic or autologous approaches for therapeutic use?. Front. Immunol. 9(2938) (2018).","DOI":"10.3389\/fimmu.2018.02938"},{"issue":"11","key":"72630_CR12","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1242\/jcs.02932","volume":"119","author":"L Da Silva Meirelles","year":"2006","unstructured":"Da Silva Meirelles, L., Chagastelles, P. C. & Nardi, N. B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci.119(11), 2204\u20132213 (2006).","journal-title":"J. Cell Sci."},{"issue":"1","key":"72630_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/stem.3077","volume":"38","author":"C M\u00e9nard","year":"2020","unstructured":"M\u00e9nard, C. et al. Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells. Stem Cells38(1), 146\u2013159 (2020).","journal-title":"Stem Cells"},{"issue":"10","key":"72630_CR14","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.1002\/jcb.26726","volume":"119","author":"VT Nooshabadi","year":"2018","unstructured":"Nooshabadi, V. T. et al. The extracellular vesicles-derived from mesenchymal stromal cells: A new therapeutic option in regenerative medicine. J. Cell. Biochem.119(10), 8048\u20138073 (2018).","journal-title":"J. Cell. Biochem."},{"key":"72630_CR15","doi-asserted-by":"crossref","unstructured":"Rozier, P., Maumus, M., Maria, A. T. J. et al. Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p. J. Autoimmun.121(102660) (2021).","DOI":"10.1016\/j.jaut.2021.102660"},{"issue":"3","key":"72630_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.addr.2012.07.001","volume":"65","author":"RW Yeo","year":"2013","unstructured":"Yeo, R. W. et al. Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery. Adv. Drug Deliv. Rev.65(3), 336\u2013341 (2013).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"72630_CR17","doi-asserted-by":"crossref","unstructured":"Kalluri, R. & Lebleu, V. S. The biology, function, and biomedical applications of exosomes. Science (New York, NY) 367(6478) (2020).","DOI":"10.1126\/science.aau6977"},{"issue":"19","key":"72630_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1089\/scd.2021.0112","volume":"30","author":"M Li","year":"2021","unstructured":"Li, M. et al. Mesenchymal stem cell-derived exosomes ameliorate dermal fibrosis in a murine model of bleomycin-induced scleroderma. Stem Cells Dev.30(19), 981\u2013990 (2021).","journal-title":"Stem Cells Dev."},{"issue":"1","key":"72630_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","volume":"16","author":"B Hinz","year":"2020","unstructured":"Hinz, B. & Lagares, D. Evasion of apoptosis by myofibroblasts: A hallmark of fibrotic diseases. Nat. Rev. Rheumatol.16(1), 11\u201331 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"72630_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/annrheumdis-2018-213455","volume":"78","author":"W Wu","year":"2019","unstructured":"Wu, W. et al. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Ann. Rheum. Dis.78(5), 648\u2013656 (2019).","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"72630_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41584-022-00765-9","volume":"18","author":"AL Herrick","year":"2022","unstructured":"Herrick, A. L., Assassi, S. & Denton, C. P. Skin involvement in early diffuse cutaneous systemic sclerosis: An unmet clinical need. Nat. Rev. Rheumatol.18(5), 276\u2013285 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"72630_CR22","doi-asserted-by":"crossref","unstructured":"Xiao, Y., Huang, Z., Wang, Y. et al. Progress in research on mesenchymal stem cells and their extracellular vesicles for treating fibrosis in systemic sclerosis. Clin Exp Med (2023).","DOI":"10.1007\/s10238-023-01136-8"},{"issue":"7","key":"72630_CR23","doi-asserted-by":"publisher","first-page":"e0218068","DOI":"10.1371\/journal.pone.0218068","volume":"14","author":"A Almadori","year":"2019","unstructured":"Almadori, A. et al. Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. PLoS One14(7), e0218068 (2019).","journal-title":"PLoS One"},{"issue":"1","key":"72630_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13287-022-02923-y","volume":"13","author":"RH S\u00f8ndergaard","year":"2022","unstructured":"S\u00f8ndergaard, R. H. et al. Adipose-derived stromal cells increase the formation of collagens through paracrine and juxtacrine mechanisms in a fibroblast co-culture model utilizing macromolecular crowding. Stem Cell Res. Ther.13(1), 250 (2022).","journal-title":"Stem Cell Res. Ther."},{"key":"72630_CR25","doi-asserted-by":"crossref","unstructured":"Baer, P. C. & Geiger, H. Adipose-derived mesenchymal stromal\/stem cells: Tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012(812693) (2012).","DOI":"10.1155\/2012\/812693"},{"issue":"1","key":"72630_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13770-021-00405-5","volume":"19","author":"Y Yu","year":"2022","unstructured":"Yu, Y. et al. The therapeutic effects of exosomes derived from human umbilical cord mesenchymal stem cells on scleroderma. Tissue Eng. Regen. Med.19(1), 141\u2013150 (2022).","journal-title":"Tissue Eng. Regen. Med."},{"key":"72630_CR27","doi-asserted-by":"crossref","unstructured":"Rozier, P., Maumus, M. & Bony C. et al. Extracellular vesicles are more potent than adipose mesenchymal stromal cells to exert an anti-fibrotic effect in an in vitro model of systemic sclerosis. Int. J. Mol. Sci. 22(13) (2021).","DOI":"10.3390\/ijms22136837"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72630-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72630-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72630-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T20:37:05Z","timestamp":1740775025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72630-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["72630"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72630-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval was granted by the Ethics Committee of Huashan and Zhongshan Hospitals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors agreed to the participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agreed to the publication of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"7162"}}